Why is colorectal cancer aggressive in younger patients? Boston researchers discover new clues - WCVB

Boston-based researchers have identified biological markers in tumors that may explain why colorectal cancer is more aggressive in younger patients. The study found patterns related to chemotherapy resistance and cell signaling, providing a foundation for future treatment research.
Why it matters
Understanding the biological differences in early-onset cancer is vital for developing targeted therapies and improving survival rates for younger demographics.
Boston-based researchers announced Wednesday the discovery of new biological clues about why colorectal cancer can behave more aggressively in young patients. The findings are based on the analysis of 189 tumors from patients, including 54 who were diagnosed with the cancer before age 50. Researchers measured gene activity in hundreds of thousands of cells and found patterns linked to chemotherapy resistance. The team, which consisted of researchers from the Dana-Farber Cancer Institute, Mass General Brigham, the Broad Institute and the Gene Lay Institute of Immunology and Inflammation, published their work in "Nature Medicine." "Among tumors of the most common colorectal cancer subtype, younger patients’ tumors had a significantly higher proportion of connective and supporting cells relative to cancer cells," according to an announcement from the group.
Also covering this story
One other newsroom covered this event. We read that version too.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in